Logo image
Analogues of Fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas Disease
Journal article   Peer reviewed

Analogues of Fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas Disease

M. Keenan, M.J. Abbott, P.W. Alexander, T. Armstrong, W.M. Best, B.M. Berven, A. Botero Gomez, J.H. Chaplin, S.A. Charman, E. Chatelain, …
Journal of Medicinal Chemistry, Vol.55(9), pp.4189-4204
2012
url
Link to Published Version *Subscription may be requiredView

Abstract

We report the discovery of nontoxic fungicide fenarimol (1) as an inhibitor of Trypanosoma cruzi (T. cruzi), the causative agent of Chagas disease, and the results of structure-activity investigations leading to potent analogues with low nM IC 50s in a T. cruzi whole cell in vitro assay. Lead compounds suppressed blood parasitemia to virtually undetectable levels after once daily oral dosing in mouse models of T. cruzi infection. Compounds are chemically tractable, allowing rapid optimization of target biological activity and drug characteristics. Chemical and biological studies undertaken in the development of the fenarimol series toward the goal of delivering a new drug candidate for Chagas disease are reported.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.261 Parasitology - Trypanosoma & Leishmania
1.261.596 Trypanosoma Biology
Web Of Science research areas
Chemistry, Medicinal
ESI research areas
Chemistry
Logo image